FDA Drug information
ZEPBOUND
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- ZEPBOUND TIRZEPATIDE 10 mg/.5mL Eli Lilly and Company
- ZEPBOUND TIRZEPATIDE 12.5 mg/.5mL Eli Lilly and Company
- ZEPBOUND TIRZEPATIDE 15 mg/.5mL Eli Lilly and Company
- ZEPBOUND TIRZEPATIDE 2.5 mg/.5mL Eli Lilly and Company
- ZEPBOUND TIRZEPATIDE 5 mg/.5mL Eli Lilly and Company
- ZEPBOUND TIRZEPATIDE 7.5 mg/.5mL Eli Lilly and Company
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.